United Therapeutics CorporationUTHRNASDAQ
LOADING
|||
Revenue Scaling
Trending higher, above historical average, modest growth trend.
Left:
||||
Total revenue from sales of goods and services
Latest
$2.88B
↑ 58% above average
Average (9y)
$1.82B
Historical baseline
Range
High:$2.88B
Low:$1.45B
CAGR
+7.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $2.88B | +23.6% |
| 2023 | $2.33B | +20.2% |
| 2022 | $1.94B | +14.9% |
| 2021 | $1.69B | +13.6% |
| 2020 | $1.48B | +2.4% |
| 2019 | $1.45B | -11.0% |
| 2018 | $1.63B | -5.7% |
| 2017 | $1.73B | +7.9% |
| 2016 | $1.60B | +9.1% |
| 2015 | $1.47B | - |